A 45-year-old woman with T2DM (A1c 8.1%) and BMI 36 kg/m² seeks weight loss and CV risk reduction. Which antihyperglycemic class confers established M...

Question

A 45-year-old woman with T2DM (A1c 8.1%) and BMI 36 kg/m² seeks weight loss and CV risk reduction. Which antihyperglycemic class confers established MACE reduction?

Accepted Answer

GLP-1 receptor agonist (e.g., semaglutide)

Answer

DPP-4 inhibitor

Answer

Sulfonylurea

Answer

Basal insulin

Answer

Meglitinide

us-abfm MCQ (SBA): Type 2 Diabetes-CV Risk

A 45-year-old woman with T2DM (A1c 8.1%) and BMI 36 kg/m² seeks weight loss and CV risk reduction. Which antihyperglycemic class confers established MACE reduction?